DBVT Competitors & Alternatives
Compare DBV Technologies with similar stocks in the same industry
Biotechnology
DBVT
Main Stock$9.77
Tradestie Score
61
Market Cap
$275.54M
Revenue Growth
-0.5%
Analyst Upside
+296.3%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 49 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$9.83
|
$665.30M | 11.5 | 63 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$14.04
|
$626.91M | - | 59 | Compare |
|
SVRA
Savara Inc.
|
$4.61
|
$611.84M | - | 66 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 49 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$2.43
|
$552.46M | - | 61 | Compare |
|
VSTM
Verastem, Inc.
|
$9.57
|
$541.60M | - | 44 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.32
|
$540.97M | - | 65 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$10.49
|
$529.35M | 11.4 | 62 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.56
|
$512.39M | - | 67 | Compare |
More DBVT Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2836)
221 stocks in this industry